Michael Liptay to Antineoplastic Agents
This is a "connection" page, showing publications Michael Liptay has written about Antineoplastic Agents.
Connection Strength
0.099
-
Complications from induction regimens for thoracic malignancies. Perioperative considerations. Chest Surg Clin N Am. 1999 Feb; 9(1):79-95.
Score: 0.037
-
Mesothelioma and radical multimodality therapy: who benefits? Chest. 1995 Jun; 107(6 Suppl):345S-350S.
Score: 0.029
-
Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):303-12.
Score: 0.026
-
An historical perspective of multi-modality treatment for resectable non-small cell lung cancer. Lung Cancer. 1995 Jun; 12 Suppl 2:S17-32.
Score: 0.007